If we compare these metrics to the Q4 2021. Total revenue of 7 mil vs 6.7 mil which is an increase of approx 5%. Net loss of 5.9 mil compared to 4.7 mil which is close to 26% increase in costs. Higher costs for less return. Probably doesn't bode well. The expanded Medicare reimbursement is our saving grace. Interesting to see how this opens up.
If we compare these metrics to the Q4 2021. Total revenue of 7...
-
- There are more pages in this discussion • 42 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add AVH (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$2.63 |
Change
0.160(6.48%) |
Mkt cap ! $174.3M | |||
| Open | High | Low | Value | Volume |
| $2.54 | $2.63 | $2.54 | $684.8K | 264.4K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 5 | 12743 | $2.60 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $2.63 | 17385 | 3 |
View Market Depth
| Last trade - 12.54pm 12/07/2024 (20 minute delay) ? |
| AVH (ASX) Chart |